SEC's 'Shadow Trading' Suit Dives Into Murky Area Of Law
The U.S. Securities and Exchange Commission is entering uncharted legal waters with an insider trading suit against a biopharmaceutical executive for allegedly engaging in a practice that's become known as "shadow...To view the full article, register now.
Already a subscriber? Click here to view full article